Natixis Investment Managers International’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-9,527
Closed -$1.6M 331
2022
Q2
$1.6M Sell
9,527
-4,140
-30% -$889K 0.03% 165
2022
Q1
$3.42M Buy
+13,667
New +$3.43M 0.06% 84
2021
Q2
Sell
-151,895
Closed -$28.6M 209
2021
Q1
$28.6M Sell
151,895
-9,305
-6% -$1.64M 1.96% 21
2020
Q4
$26.5M Buy
+161,200
New +$23.6M 1.85% 22
2018
Q4
Sell
-23,204
Closed -$3.23M 262
2018
Q3
$3.23M Buy
23,204
+12,699
+121% +$1.58M 0.15% 98
2018
Q2
$1.08M Buy
+10,505
New +$1.06M 0.06% 253
2015
Q4
Sell
-279
Closed -$22K 428
2015
Q3
$22K Sell
279
-4,862
-95% -$431K ﹤0.01% 422
2015
Q2
$466K Buy
+5,141
New +$412K 0.06% 204
2015
Q1
Sell
-2,388
Closed -$175K 447
2014
Q4
$175K Buy
+2,388
New +$168K 0.02% 270

Other funds holding HCA

Natixis Investment Managers International's HCA Position: Q3 2022 in Review

Natixis Investment Managers International sold out of HCA Healthcare (HCA) in Q3 2022, closing a stake of 9,527 shares — an estimated $1.6M sold.

Natixis Investment Managers International first reported a position in HCA in Q4 2014 and held it in 9 quarters. The position peaked at $28.6M in Q1 2021. 868 funds tracked by Wall St. Rank hold HCA as of Q3 2022.

  • Natixis Investment Managers International reported no remaining HCA Healthcare position as of Q3 2022 after selling out during the quarter.
  • Natixis Investment Managers International sold 9,527 HCA Healthcare shares in Q3 2022, an estimated $1.6M.
  • Natixis Investment Managers International first reported a position in HCA Healthcare in Q4 2014 and held it in 9 quarters.
  • Natixis Investment Managers International's HCA Healthcare position peaked at $28.6M in Q1 2021.
  • 868 funds tracked by Wall St. Rank held HCA Healthcare as of Q3 2022.

Based on Natixis Investment Managers International's 13F filing for Q3 2022, filed 14 Nov 2022.